A phase I/II study of nebulized morphine-6-glucuronide in patients with cancer-related breathlessness.
Quigley
Columba
C
Joel
Simon
S
Patel
Naina
N
Baksh
Amina
A
Slevin
Maurice
M
D000280:Administration, Inhalation; D017322:Clinical Trials, Phase II as Topic; D004417:Dyspnea / Q000188:drug therapy* / Q000209:etiology*; D006801:Humans; D009022:Morphine Derivatives / Q000008:administration & dosage* / Q000627:therapeutic use; D009330:Nebulizers and Vaporizers; D009369:Neoplasms / Q000150:complications*
D009022:Morphine Derivatives; C035349:morphine-6-glucuronide